DOI: https://dx.doi.org/10.18203/2319-2003.ijbcp20220404
Published: 2022-02-23

Comparison of the effect of kalsitrapine and metformin as adjunctive therapy in the treatment of infertility in women with polycystic ovary syndrome

Faranak Jalilvand, Shahla Farzipour, Firouz Amani, Susan Houshmandi, Sajjad Naeimi

Abstract


Background: Chronic anovulation is one of the most common causes of infertility. In women with polycystic ovary syndrome (PCOS), other factors related to oocyte quality or endometrial and nesting disorders may also play a role. Infertile and non-ovulatory women who tend to become pregnant are candidates for ovulation induction. The aim of this study was to evaluate the effect of Kalsitrapine and metformin on the treatment of patients with PCOS.

Methods: The clinical trial study was performed on 80 female patients with PCOS who had referred to Ardabil city hospital for infertility treatment were randomly divided in two groups with personal consent. One group received Kalsitrapine and another group received metformin.

Results: The mean age of all patients was 26.08±5.21. There was no significant difference between 2 groups in term of age and BMI. There was no statistically significant difference between the two groups in terms of primary and secondary infertility. The mean duration of infertility was 3.68±3.49 years. There was no statistically significant difference between the 2 groups in terms of infertility duration. There was no statistically significant difference between the 2 groups in terms of the type of menstrual cycle. The response rate to treatment was 17.5% in the metformin group and 10% in the Kalsitrapine group. There was no statistically significant difference between the 2 groups in terms of response to treatment. In comparison, none of the studied factors in the 2 groups was significantly associated with the response to treatment.

Conclusions: It is true that the recovery rate of the herbal medicine Kalcitropine in this study was slightly lower than metformin, but due to the side effects of metformin, including lethargy, abdominal pain, diarrhea, headache, constipation, bloating, weight loss, heartburn, nausea and Vomiting, unpleasant taste of metal in the mouth In some people, such people may be prescribed kalcitrapine for a longer period of time to evaluate its effect.


Keywords


Kalsitrapine, Metformin, Infertility, Women, PCOS

Full Text:

PDF

References


McCartney CR, Marshall JC. Polycystic Ovary Syndrome. N Engl J Med. 2016;375(1):54-64.

Arentz S, Smith CA, Abbott J, Fahey P, Cheema BS, Bensoussan A. Combined lifestyle and herbal medicine in overweight women with polycystic ovary syndrome (PCOS): A randomized controlled trial. Phytotherapy Res. 2017;31(9):1330-40.

Teng B, Peng J, Ong M, Qu X. Successful Pregnancy after Treatment with Chinese Herbal Medicine in a 43‐Year‐Old Woman with Diminished Ovarian Reserve and Multiple Uterus Fibrosis: A Case Report. Medicines. 2017;4(1):7.

Lai L, Flower A, Moore M, Lewith G. Chinese herbal medicine and polycystic ovary syndrome: A randomized feasibility and pilot study in the United Kingdom. J Alternative Complementary Med. 2014;20(5):61-2.

Shayan A, Masoumi SZ, Shobeiri F, Tohidi S, Khalili A. Comparing the Effects of Agnugol and Metformin on Oligomenorrhea in Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial. J Clin Diagnostic Res. 2016;10(12):13.

Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013;6(1):1-13.

Badawy A, Elnashar A. Treatment options for polycystic ovary syndrome. Int J Women’s Health. 2011;12(3):25-35.

Kashani L, Akhondzadeh S. Herbal Medicine in the Treatment of Polycystic Ovary Syndrome. Herbal Med J. 2016;3(59):1-5.

Nandi A, Chen Z, Patel R, Poretsky L. Polycystic ovary syndrome. Endocrinol Metabol Clin North Am. 2014;43(5):123-47.

Lai L, Flower A, Prescott P, Moore M, Lewith G. Chinese herbal medicine for oligomenorrhoea and amenorrhoea in polycystic ovary syndrome: A 4 randomized feasibility study in the United Kingdom. Integrative Med Res. 2015;4(1):15.

Arentz S, Abbott JA, Smith CA, Bensoussan A. Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo‏/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings. BMC Complementary Alternative Med. 2014;14(1):511.

Kamalanathan S, Sahoo JP, Sathyapalan T. Pregnancy in polycystic ovary syndrome. Indian J Endocrinol Metab. 2013;17(1):37-43.

Lashen H. Review: Role of metformin in the management of polycystic ovary syndrome. Therapeutic Advances in Endocrinology and Metabolism. 2010;12(1):117–28.

Roe AH, Dokras A. The diagnosis of polycystic ovary syndrome in adolescents. Rev Obstet Gynecol. 2011;4(2):45-51.

Pauli JM, Raja-Khan N, Wu X, Legro RS. Current perspectives of insulin resistance and polycystic ovary syndrome. Diabet Med. 2011;28(12):1445-54.

Lai L, Flower A, Moore M, Prescott P, Lewith G. Polycystic ovary syndrome: a 4 randomized feasibility and pilot study using Chinese Herbal medicine to explore Impact on Dysfunction (ORCHID)- study protocol. Eur J Integrative Med. 2014;6(3):392-9.

Goswami PK, Khale A, Ogale S. Natural remedies for polycystic ovarian syndrome (PCOS): a review. Int J Pharmaceutical Phytopharmacological Res. 2017;1(6):396-402.

Wu XK, Wang YY, Liu JP, Hou LH, Gao YQ, Du SM et al. Letrozole, berberine, or a combination for infertility in Chinese women with polycystic ovary syndrome: a 4 randomized, double-blind, placebo-controlled trial. Lancet. 2015;31(386):70.

Yilmaz M, Karakoc A. The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome. Gynecol Endocrinol. 2015;21(3):154-60.

Krstevska B, Dimitrovski CH. Metformin improves menstrual patterns, endocrine and metabolic profile in obese hyperinsulinemic women with a polycystic ovary syndrome. Prilozi. 2016;27(1):57-66.

Amooee S, Parsanezhad ME, Ravanbod Shirazi M, Alborzi S, Samsami A. Metformin versus chromium picolinate in clomiphene citrate-resistant patients with PCOS: A double-blind randomized clinical trial. IJRMS. 2013;11(8):611.

Baran S, Api M, Goksedef BP, Cetin A. Comparison of metformin and clomiphene citrate therapy for induction of ovulation in the polycystic ovary syndrome. Arch Gynecol Obstet. 2010;282(4):439-43.

Azargoon A, Alavi Toussy J. Comparison of pregnant and non-pregnant women with clomiphene resistant polycystic ovary syndrome in treatment with metformin and letrozole. Koomesh. 2011;12(3):327-33.